Lexicon Pharmaceuticals
LXRX
#6598
Rank
โ‚น61.63 B
Marketcap
โ‚น145.47
Share price
-3.70%
Change (1 day)
366.75%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น11.20 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has โ‚น11.20 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น12.52 B61.53%
2023-12-31$โ‚น7.75 B-20.02%
2022-12-31$โ‚น9.69 B14.63%
2021-12-31$โ‚น8.45 B-26.07%
2020-12-31$โ‚น11.43 B36.95%
2019-12-31$โ‚น8.35 B-552.29%
2018-12-31$-โ‚น1.85 Billion-142.36%
2017-12-31$โ‚น4.35 B-59.25%
2016-12-31$โ‚น10.69 B-43.69%
2015-12-31$โ‚น18.99 B5.53%
2014-12-31$โ‚น18.00 B71.23%
2013-12-31$โ‚น10.51 B-28%
2012-12-31$โ‚น14.60 B-7.24%
2011-12-31$โ‚น15.74 B42.21%
2010-12-31$โ‚น11.06 B45.91%
2009-12-31$โ‚น7.58 B-19.4%
2008-12-31$โ‚น9.41 B-16.31%
2007-12-31$โ‚น11.24 B196.99%
2006-12-31$โ‚น3.78 B-1.92%
2005-12-31$โ‚น3.86 B-26.68%
2004-12-31$โ‚น5.26 B-30.42%
2003-12-31$โ‚น7.56 B-7.12%
2002-12-31$โ‚น8.14 B-22.67%
2001-12-31$โ‚น10.53 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น4.770 T 42,471.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น253.92 B 2,166.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น2.914 T 25,912.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น1.50 B-86.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น88.60 B 690.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น42.1 Billion-475.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น15.3 Billion-236.47%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น564.80 B 4,940.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.33 B-97.03%๐Ÿ‡บ๐Ÿ‡ธ USA